| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |